GLUCAGON
From CRS EMS Guidelines
Revision as of 21:38, 3 April 2022 by Cgabryszek (talk | contribs) (Created page with "'''Class''' Hormone (antihypoglycemic agent) '''Pharmacology and Actions''' # Increases blood sugar concentration by converting liver glycogen to glucose. # Relaxes smooth muscle of the GI tract. # Increases heart rate and cardiac contractility. '''Indications''' # Symptomatic hypoglycemia when IV access is unsuccessful. # Hypotensiion from beta-blocker or calcium channel blocker overdose unresponsive to normal saline bolus. # Suspected symptomatic esophageal foreig...")
Class
Hormone (antihypoglycemic agent)
Pharmacology and Actions
- Increases blood sugar concentration by converting liver glycogen to glucose.
- Relaxes smooth muscle of the GI tract.
- Increases heart rate and cardiac contractility.
Indications
- Symptomatic hypoglycemia when IV access is unsuccessful.
- Hypotensiion from beta-blocker or calcium channel blocker overdose unresponsive to normal saline bolus.
- Suspected symptomatic esophageal foreign body.
Contraindications
- Hypersensitivity to the drug
Precautions
- Use with caution in patients with a history of cardiovascular disease, renal disease, pheochromocytoma or insulinoma.
Administration
- Hypoglycemia: Adult dose; 1 mg IM
- Beta blocker / Ca ++ Channel Blocker OD - Contact medical control
- Adult Dose: 2mg IV/IO
- Pediatric Dose: 0.1 mg/kg IV/IO (max dose is 1 mg).
Side Effects and Special Notes
- Nausea, vomiting, and headache.
- When glucagon is given for hypoglycemia the patient should receive glucose as soon as possible after the administration of glucagon.
